GreenPeptide Co. Ltd. | Mutual Funds
Mutual Funds that own GreenPeptide Co. Ltd.
Siemens Global Growth
98,300
0.24%
3,200
0.22%
04/30/2018
SPDR S&P World (ex-US) ETF
40,700
0.1%
200
0%
09/06/2018
GO UCITS ETF Solutions Plc - FTSE 100 Super Short Strat. (2x)
0
0%
-28,800
0%
02/28/2018
| Address |
Fukuoka Bio Incubation Center 402
Kurume Fukuoka 839
Japan
|
|
Employees
|
- |
| Website |
http://www.brightpathbio.com |
| Updated |
07/08/2019 |
| BrightPath Biotherapeutics Co., Ltd. engages in the drug development business. It focuses on the development of cancer immunotherapies. Its product candidates are based on peptide vaccine technology that stimulates a potent immune response to tumor-associated antigens. |
